Evidence map›Paper›PMID 28251801›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2017

Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance.

B Sprangers, S DeWolf, T M Savage, T Morokata, A Obradovic, S A LoCascio, B Shonts, J Zuber, S P Lau, R Shah and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Preclinical and clinical studies on kidney allograft tolerance via hematopoietic chimerism.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Tolerance Induction Strategies in Organ Transplantation: Current Status and Future Perspectives.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  7. Chimerism-Mediated Tolerance in Intestinal Transplantation.Gastroenterology clinics of North America · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Strategies for Liver Transplantation Tolerance.International journal of molecular sciences · 2021
    Review
  13. Review
  14. Expansion of CD45RAClinical & translational immunology · 2021
    Article
  15. Observational
  16. Article
  17. Deletion of donor-reactive T cell clones after human liver transplant.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  18. Article
  19. Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study.Transplant international : official journal of the European Society for Organ Transplantation · 2020
    Article
  20. CD2 Immunobiology.Frontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

B SprangersColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
S DeWolfColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
T M SavageColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
T MorokataTransplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
A ObradovicColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
S A LoCascioColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
B ShontsColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
J ZuberColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
S P LauColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
R ShahColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
H MorrisColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
V SteshenkoDivision of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, NY.
E ZornColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
F I PrefferDepartment of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
S OlekEpiontis GmbH, Berlin, Germany.
D M DombkowskiDepartment of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
L A TurkaCenter for Translational Sciences, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
R ColvinDepartment of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
R WinchesterDivision of Rheumatology, Department of Medicine, Columbia University Medical Center, New York, NY.
T KawaiTransplantation Unit, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
M SykesColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY.
Columbia University Irving Medical Center · USMassachusetts General Hospital · USHarvard University · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
Significance of Intrarenal T Cells in SLE NephritisR01DK106436 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WINCHESTER, ROBERT J · 2016 to 2019
$1.6M
Mechanisms of tolerance in recipients of combined kidney and bone marrow transplaR01AI084074 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 2009 to 2010
$862k
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI045897NIAID NIH HHS R01 AI084074NIAID NIH HHS UM1 AI109565NIDDK NIH HHS R01 DK106436NIH HHS S10 OD020056
6 · The paper itself

Abstract

We examined tolerance mechanisms in patients receiving HLA-mismatched combined kidney-bone marrow transplantation (CKBMT) that led to transient chimerism under a previously published nonmyeloablative conditioning regimen (Immune Tolerance Network study 036). Polychromatic flow cytometry and high-throughput sequencing of T cell receptor-β hypervariable regions of DNA from peripheral blood regulatory T cells (Tregs) and CD4 non-Tregs revealed marked early enrichment of Tregs (CD3

Indexed as

Bone Marrow TransplantationKidney TransplantationFemaleGraft SurvivalHumansImmune ToleranceMaleReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryTransplantation ChimeraTransplantation ToleranceReceptors, Antigen, T-Cellcellular biologyimmunobiologykidney transplantation/nephrologyT cell biologytolerancetranslational research/science

Identifiers

PMID28251801
PMCPMC5519438
OpenAlexW2593286978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.